COVID-19-associated Cryptococcus infection (CACI): a review of literature and clinical pearls
- 24 March 2022
- journal article
- review article
- Published by Springer Nature in Infection
- Vol. 50 (4) , 1007-1012
Abstract
Background Cryptococcal infection has been increasingly reported in patients with COVID-19 infection, but the epidemiological factors, presentation, diagnostic certainty, and outcome have not been well-described. Methods We reviewed the published cases of COVID-19-associated Cryptococcus infections (CACI) to shed the light on the burden of this infection. Results We identified 13 patients with confirmed cryptococcal infection. Cryptococcus infection was primarily seen in patients with severe COVID-19 disease who received corticosteroids therapy and admitted to the intensive care unit. Pulmonary CACI was the most common reported infection followed by cryptococcal meningitis. Conclusion In light of the high mortality rate, clinicians should maintain a high clinical suspicion of CACI in critically ill patients.Keywords
This publication has 32 references indexed in Scilit:
- Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?Journal of Microbiology, Immunology and Infection, 2020
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational studyThe Lancet Respiratory Medicine, 2020
- Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)Clinical Infectious Diseases, 2020
- Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research ConsortiumClinical Infectious Diseases, 2019
- Concomitant severe influenza and cryptococcal infectionsMedicine, 2019
- Pulmonary cryptococcosis: A review of pathobiology and clinical aspectsMedical Mycology, 2018
- Disseminated cryptococcosis in a patient taking tocilizumab for Castleman's diseaseJournal of Infection and Chemotherapy, 2018
- Influenza A Virus as a Predisposing Factor for CryptococcosisFrontiers in Cellular and Infection Microbiology, 2017
- CryptococcosisInfectious Disease Clinics of North America, 2016
- Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2010